Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide vs Prednisone in Active Autoimmune Hepatitis
NCT00838214Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Mar 2001
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of EPI-EE in autoimmune hepatitis (AIH), sponsored by Dr. Falk Pharma GmbH. Started Mar 2001; status: completed.
02
Drugs
EPI-EE
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT00838214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838214.